May 2024

Graduating from UC San Francisco is the end of one rewarding journey and the start of another. For the new alumni recently honored at UCSF Diversity Graduation, it not only signals the beginning of a career in health care but also an…

Many modern day Native Americans in the U.S. have multiple roots, both Indigenous and non-Indigenous. That lived experience often leaves them looking for a way to strengthen or even rebuild a connection with that Indigenous lineage…

UC San Francisco researchers have received $12.45 million from the National Cancer Institute (NCI) to lead the first long-term study of cancer among Asian Americans, a highly diverse yet understudied group. Despite a growing incidence of…

Now that smoking has replaced injecting as the most common way to consume fentanyl, UC San Francisco researchers have uncovered an increased risk of fatal overdose from the residue that accumulates in smoking equipment. The…

Scientists have known for years that a lattice of blood vessels nourishes cells in the retina that allow us to see – but it’s been a mystery how the intricate structure is created. Now, researchers at UC San Francisco have found a…

The rate of colorectal cancer screenings more than doubled when patients were given a choice between which type of screening they wanted—a take-home kit or colonoscopy—compared to those who were only offered the colonoscopy, according to…

Julia Puchtler has been named senior vice president and chief financial officer of the University of Pennsylvania Health System (UPHS), effective July 1, 2024. Puchtler currently serves as chief financial officer of the Hospital of the…

An experimental mRNA vaccine against avian influenza virus H5N1 is highly effective in preventing severe illness and death in preclinical models. The vaccine could potentially help manage the outbreak of the H5N1 virus currently…

Researchers from Penn Medicine’s Abramson Cancer Center (ACC) and the Perelman School of Medicine at the University of Pennsylvania will present data on the latest advances in cancer research at the 2024 American Society of Clinical…

Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug — dupilumab — that showed rapid and sustained improvements in patients in a pivotal Phase 3 clinical trial, researchers report in the…